Recombinant MS4A1 (Ocrelizumab Biosimilar) 抗体
This anti-MS4A1 (Ocrelizumab Biosimilar) antibody is a Mammalian Cells 单克隆 antibody detecting MS4A1 (Ocrelizumab Biosimilar) in ELISA. Suitable for 人.
Quick Overview for Recombinant MS4A1 (Ocrelizumab Biosimilar) 抗体 (ABIN7487883)
抗原
MS4A1 (Ocrelizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This MS4A1 (Ocrelizumab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Ocrelizumab Biosimilar - Anti-MS4A1, CD20 mAb
-
产品特性
- Antibody Type: IgG1-nd
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG1
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- MS4A1 (Ocrelizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
2H7
Ocrelizumab is a CD20-directed cytolytic antibody, which is suitable for the treatment of patients with relapsed or primary progressive multiple sclerosis. It is a second-generation recombinant humanized monoclonal antibody of isotype IgG1 that can selectively target B lymphocytes expressing CD20 antigen. Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system, which can cause neurological dysfunction. Most patients with MS experience recurrent episodes with functional deterioration, followed by recovery or remission. -
CAS-编号
- 637334-45-3
抗原
-
You are here:
